MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Climate Change Indices and The Vulnerability of Parkinson’s Patients in The MENA Region And North Africa: A Narrative Review

    MYA. Amine, F. Essam (Giza, Egypt)

    Objective: Through a (SWOT) analysis, this study looked at the climate change indices and the susceptibility of Parkinson's patients in the MENA region and North…
  • 2024 International Congress

    Neuroprotective Action of Exogenous Melatonin in Parkinson Disease Patients and its Impact on Daily Routine: a Systematic Review

    G. Maia, P. Silva, M. Rosa, R. Albuquerque, E. Almeida, C. Menegon, V. Serafim, F. Oliveira, G. Sorato, I. Fink, C. Rieder (Porto Alegre, Brazil)

    Objective: This study aims to evaluate the neuroprotective action of exogenous melatonin in Parkinson disease patients and its impact on daily routine. Background: Parkinson Disease…
  • 2024 International Congress

    The “Cat Killer’s Disease”: Lived Experience of Parkinson’s disease Patients in Ethiopia

    S. Seyoum, S. Gugssa, R. Walker, N. Fothergill-Misbah, W. Mersha, S. Kifelew (Addis Ababa, Ethiopia)

    Objective: The main objective of this study is to explore the lived experience of PD patients in Addis Ababa, Ethiopia. Background: Parkinson's disease (PD) is…
  • 2024 International Congress

    Boosting Parkinson’s Disease Diagnosis: How Training Ethiopian Healthcare Workers and Enhancing Community Level Awareness Led to a Surge in Case Identification

    MRS. Yinesu (Addis Ababa, Ethiopia)

    Objective: The study assessed the effectiveness of a capacity development training program in improving the diagnosis of Parkinson's Disease (PD) by healthcare professionals Background: Parkinson's…
  • 2024 International Congress

    Device-aided Recording of Gait Parameters and Motor Fluctuations in Patients with advanced Parkinson’s disease in the Home Environment

    C. Schrader (Hannover, Germany)

    Objective: To objectively assess mobility and gait parameters in the ON and OFF state in patients with advanced Parkinson's disease (PD) under everyday conditions using…
  • 2024 International Congress

    Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update

    T. Simuni, C. Coffey, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, B. Saville, C. Allen-Savietta, B. Wendelberger, A. Crawford, K. Fabrizio, K. Marek (Chicago, USA)

    Objective: To describe the study design and timeline of the first interventional study in  Neuronal α-Synuclein Disease (NSD). Background: P2P is a platform, Phase 2…
  • 2024 International Congress

    Establishing α-Synuclein Seeding Activity in Saliva as a Noninvasive Diagnostic Biomarker for Parkinson’s Disease

    Z. Wang, S. Gunzler, S. Chen, Q. Kong (Cleveland, USA)

    Objective: To establish α-synuclein seeding activity in saliva as a noninvasive diagnostic biomarker for Parkinson’s disease (PD). Background: PD is the second most common neurodegenerative…
  • 2024 International Congress

    Influence of immigration on Parkinson’s disease: analysis of clinical presentation.

    A. Peral Quirós, N. Caballol Pons, A. Planas Ballvé, M. Balagué Marmaña, MI. Gómez Ruiz, A. ávila Rivera (Barcelona, Spain)

    Objective: To analyze the epidemiological and clinical presentation in our immigrants patients with Parkinson’s disease (PD) from our reference population in Barcelona, Spain. Background: In…
  • 2024 International Congress

    Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study

    A. Huang, A. Wise, V. Shanker (New York, USA)

    Objective: To assess if presence of cognitive side effects during an initial levodopa trial suggests the ultimate diagnosis of atypical Parkinson (APD) vs Parkinson disease…
  • 2024 International Congress

    The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population

    KC. Dey, D. Mair, A. Zirra, E. Camboe, T. Zannat, S. Haque, RS. Weil, DA. Gallagher, C. Budu, T. Haque, S. Ali, N. Mukadam, A. Habib, AJ. Noyce, CR. Marshall, S. Waters (London, United Kingdom)

    Objective: To establish whether a visuoperceptual tool (the Cats-and-Dogs test) can predict cognitive impairment (CI) in people with Parkinson’s disease (PwP) in a diverse population.…
  • « Previous Page
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley